Ubs Group Ag Sol Gel Technologies Ltd. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 21,258 shares of SLGL stock, worth $13,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,258
Previous 3,459
514.57%
Holding current value
$13,392
Previous $2,000
850.0%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding SLGL
# of Institutions
21Shares Held
5.31MCall Options Held
12.8KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.56 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$773,3550.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$579,8090.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3227KShares$143,0590.04% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL109KShares$68,6630.0% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $14.6M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...